Cellecta
Cellecta, Inc is a trusted provider of functional genomic products and services with over 15 years experience working with the world’s leading pharma, biotech, and academic institutions. Our portfolio includes products and services for loss-of-function and gain-of-function phenotypic screening, cell barcoding and Targeted RNA-Seq expression profiling. This includes design and manufacture of custom and off-the-shelf, ready-to-use CRISPR and RNAi libraries, lentiviral constructs and cell engineering services. We also offer expression profiling assays and spatial transcriptomic services for drug target and biomarker discovery and other applications.
TCR Repertoire Profiling Reveals Clonality of Immuno-STAT Primed CD8+ T Cells
Advancements in TCR/BCR Repertoire Profiling and TCR-Epitope Interactions
Functional transcriptomics for isoform level dissection of lncRNA cancer dependencies
Qualitative assessment of the quality of immune response by analyzing B- and T-cell clonotypes
An overview of Cellecta Technologies
A guide for adaptive immune receptor profiling & characterization of antigen-induced clonotypes
Using Adaptive Immune Receptor Repertoire Profiling to Characterize Rare Immune Excluded Tumors
Blood Immune Receptor Repertoire and Transcriptome Profiling in a Murine Tuberculosis Model
TCR & BCR Repertoire Analysis, AAI 2024 Presentation by Alex Chenchik, PhD, from Cellecta, Inc
Dissecting the role of T-cell receptors in T-cell large granular lymphocytic leukemias
TCR & BCR Repertoire Analysis for the Discovery of Drug Targets, Resistance Mechanisms & Biomarkers
Cellecta Overview
Improved Adaptive Immune Receptor Repertoire Profiling for Biomarker Discovery
TCR and BCR Repertoire Analysis Exhibitor Workshop from Immunology2023
An integrated approach to identify regulatory mechanisms in breast cancer development & progression
Adaptive Immune Receptor Profiling for Biomarker Discovery - Alex Chechik
Immunophenotyping of T- and B-Cell Receptors - Alex Chenchik
Cellecta Single Cell CRISPR screening; by Paul Diehl, PhD, Cellecta, Inc
A functional map of LncRNAs involved in adaptation pathways of breast cancer cells; by Matteo Marzi
Perturb-seq analysis of TNFalpha-induced transcriptional response; by Donato Tedesco, PhD
Mapping Long Noncoding RNA Dependencies in Tumor Cells; by Eugenio Morelli M.D.
Immunophenotyping of T and B-Cell Receptors; by Alex Chenchik, President, Cellecta, Inc
Development of a multitarget therapy for prostate cancer; by Maria J. Ruiz-Echevarria, PhD
Flexible & Scalable Genetic Screens for Novel Therapeutic Target Discovery- Overview of Case Studies
Spatial Transcriptomics: Uses and Limitations of a Powerful Technique
Immunophenotyping of TCR and BCR Clonotypes
Improving and Optimizing Sequencing Workflows
Phenotypic screening hit target deconvolution using CRISPR/Cas9 screening technology | AAPS 2021
CRISPR 2.0-Functional CRISPR screening and Cell Barcoding by Paul Diehl